Guangxi LiuYao Group Co Ltd
SSE:603368
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Guangxi LiuYao Group Co Ltd
Capital Expenditures
Guangxi LiuYao Group Co Ltd
Capital Expenditures Peer Comparison
1099
601607
600998
000963
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
G
|
Guangxi LiuYao Group Co Ltd
SSE:603368
|
Capital Expenditures
-¥176.6m
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Capital Expenditures
-¥2.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Capital Expenditures
-¥3.2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-14%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Capital Expenditures
-¥960.2m
|
CAGR 3-Years
15%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-4%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Capital Expenditures
-¥143.1m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-1%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Capital Expenditures
-¥1.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-17%
|
See Also
What is Guangxi LiuYao Group Co Ltd's Capital Expenditures?
Capital Expenditures
-176.6m
CNY
Based on the financial report for Mar 31, 2024, Guangxi LiuYao Group Co Ltd's Capital Expenditures amounts to -176.6m CNY.
What is Guangxi LiuYao Group Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
11%
Over the last year, the Capital Expenditures growth was -5%. The average annual Capital Expenditures growth rates for Guangxi LiuYao Group Co Ltd have been 16% over the past three years , 11% over the past five years .
You don't have any saved screeners yet
